Nature Biotechnology
A monthly journal covering the science and business of biotechnology, with new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences.
Harnessing Type I CRISPR–Cas systems for genome engineering in human cells
Using a FokI fusion design, we show that Type I CRISPR-Cas systems can be expressed, reconstituted, and faithfully trafficked to the nucleus for genome engineering in human cells
How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers; nature-based products; diagnostics; and algorithms, big data and AI?
Behind the paper "How does the emerging patent case law in the US and Europe affect precision medicine?"
